Guardian Pharmacy Services, Inc. (GRDN) - Stock Analysis

Last updated: Sep 19, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

GRDN rose 14.4% over 21 sessions to a September 11 high. The company raised full-year guidance, expanded residents served by 8%, completed pharmacy-related acquisitions, and has a September 15 healthcare conference that could generate additional operating commentary.

Loading chart data...

Idea window: 9/11/2026 – 9/18/2026Sector: Healthcare

AI Analyst Overview

Last Price
$41.28
Market Cap
$2.61B
1D Return
-0.77%
YTD Return
+37.19%

Loading chart data...

Valuation Metrics

P/E
39.3
P/B
10.6
P/S
1.8
EV/EBITDA
21.9
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Margin Expansion • Lower Leverage • Strong Liquidity GRDN's improving margins, liquidity, deleveraging, and cash generation support stronger operations, but elevated valuation and share-based compensation warrant caution.

OperationalStrength
ValuationRisk

Price Behavior

5.0

Key Price Behavior Insights: • Strong monthly rally • Peak pullback • Overbought momentum Support Level: $43.40–$43.80 Resistance Level: $48.00 GRDN gained ~20% last month but, with RSI near 78 and a retreat from $48.00, traders should watch $43.40–$43.80 support and $48.00 resistance for confirmation of the next move.

Bullish
Overbought

Sentiment & News

6.0

Key News Insights: • Institutional buying • Asset acquisition • Investor conference Guardian Pharmacy Services gained institutional backing, expanded via Nautilus Pharmacy assets, and will engage investors at Jefferies.

Growth
InvestorFocus
AI

AI Summary

6.0
Neutral

GRDN's upside hinges on proving that 8% resident growth and recent acquisitions can sustain ~10% EBITDA margins and translate into diluted per-share free-cash-flow growth, but its premium valuation leaves little room for integration missteps, margin reversion, or weak revenue monetization.

MarginExpansion
ValuationRisk
AcquisitionExecution
AI summary updated 21 days ago

Description

Guardian Pharmacy Services provides pharmacy and clinical medication services to residents of lower-acuity long-term care facilities across the United States, including assisted living, behavioral health facilities and group homes. The company pairs medication dispensing and administration with operational tools—such as dashboards built from its data warehouse—and programmatic offerings for facility clients. Guardian Pharmacy Services was founded in 2003 and is headquartered in Atlanta, Georgia.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Sep 11Sep 18GRDNGuardian Pharmacy Services, Inc.
GRDN rose 14.4% over 21 sessions to a September 11 high. The company raised full-year guidance, expanded residents served by 8%, completed pharmacy-related acquisitions, and has a September 15 healthcare conference that could generate additional operating commentary.
Closed+3.1%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.